Consequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|9|4|693-705

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.9, Iss.4, 2011-12, pp. : 693-705

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Contributions of Brain Insulin Resistance and Deficiency in Amyloid-Related Neurodegeneration in Alzheimer's Disease

By >  

Drugs, Vol. 72, Iss. 1, 2012-01 ,pp. : 49-66

Adis International

Access to resources Recommend Favorite

Insulin resistance and Alzheimer's disease

By  

Inpharma, Vol. 1, Iss. 1371, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Rivastigmine, a brain-region selective acetylcholinesterase inhibitor for treating Alzheimer’s disease: review and current status

By Gottwald M.D.   Rozanski R.I.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1673-1682

Informa Healthcare

Access to resources Recommend Favorite

Non-Cholinergic Strategies for Treating and Preventing Alzheimer's Disease

By Doraiswamy P.M.  

CNS Drugs, Vol. 16, Iss. 12, 2002-01 ,pp. : 811-824

Adis International

Access to resources Recommend Favorite

Alzheimer Disease: What Role for Leptin and Insulin?

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 6, Iss. 4, 2006-12 ,pp. : 271-279

Bentham Science Publishers

Access to resources Recommend Favorite